Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-13 5:03 pm Sale | 2025-08-11 | 13G | VERASTEM INC VSTM | BIOTECHNOLOGY VALUE FUND L P | 2,500,000 3.900% | -3,220,831 (-56.30%) | Filing History |
| 2025-08-13 5:00 pm Purchase | 2025-06-30 | 13G | VERASTEM INC VSTM | BIOTECHNOLOGY VALUE FUND L P | 5,720,831 9.990% | 1,014,280 (+21.55%) | Filing History |
| 2025-08-07 4:31 pm Purchase | 2025-08-05 | 13D | ESSA PHARMA INC EPIX | BIOTECHNOLOGY VALUE FUND L P | 11,668,473 24.700% | 2,919,844 (+33.37%) | Filing History |
| 2025-07-21 6:36 pm Sale | 2025-07-17 | 13G | OVID THERAPEUTICS INC OVID | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -3,853,818 (Position Closed) | Filing History |
| 2025-07-09 7:55 pm Sale | 2025-07-03 | 13G | CYTOMX THERAPEUTICS INC CTMX | BIOTECHNOLOGY VALUE FUND L P | 5,769,231 3.500% | -5,769,231 (-50.00%) | Filing History |
| 2025-07-09 7:53 pm Purchase | 2025-06-30 | 13G | CYTOMX THERAPEUTICS INC CTMX | BIOTECHNOLOGY VALUE FUND L P | 11,538,462 6.800% | 3,448,667 (+42.63%) | Filing History |
| 2025-07-09 4:39 pm Purchase | 2025-07-01 | 13G | NEKTAR THERAPEUTICS NKTR | BIOTECHNOLOGY VALUE FUND L P | 1,276,595 7.400% | 1,094,280 (+600.21%) | Filing History |
| 2025-06-16 5:30 pm Purchase | 2025-06-09 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | BIOTECHNOLOGY VALUE FUND L P | 3,211,041 5.200% | 240,614 (+8.10%) | Filing History |
| 2025-05-20 6:52 pm Sale | 2025-05-16 | 13D | XOMA ROYALTY CORPORATION COMMO XOMA | BIOTECHNOLOGY VALUE FUND L P | 2,590,303 21.600% | -392,723 (-13.17%) | Filing History |
| 2025-05-19 6:42 pm Sale | 2025-05-15 | 13G | ALLAKOS INC ALLK | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -16,552,417 (Position Closed) | Filing History |
| 2025-05-15 4:42 pm Purchase | 2025-03-31 | 13G | VIGIL NEUROSCIENCE INC VIGL | BIOTECHNOLOGY VALUE FUND L P | 4,734,500 9.990% | 1,994,773 (+72.81%) | Filing History |
| 2025-05-15 4:40 pm Purchase | 2025-03-31 | 13G | TSCAN THERAPEUTICS INC TCRX | BIOTECHNOLOGY VALUE FUND L P | 5,263,541 9.990% | 190,538 (+3.76%) | Filing History |
| 2025-05-15 4:37 pm Purchase | 2025-03-31 | 13G | SEPTERNA INC SEPN | BIOTECHNOLOGY VALUE FUND L P | 4,396,124 9.900% | 1,944,100 (+79.29%) | Filing History |
| 2025-05-15 4:35 pm Purchase | 2025-03-31 | 13G | ITEOS THERAPEUTICS INC. ITOS | BIOTECHNOLOGY VALUE FUND L P | 3,075,000 8.100% | 750,000 (+32.26%) | Filing History |
| 2025-05-15 4:33 pm Purchase | 2025-03-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | BIOTECHNOLOGY VALUE FUND L P | 5,660,132 9.200% | 1,266,922 (+28.84%) | Filing History |
| 2025-05-15 4:31 pm Sale | 2025-03-31 | 13G | GH RESH PLC SHS GHRS | BIOTECHNOLOGY VALUE FUND L P | 8,827,712 14.200% | -1,572,446 (-15.12%) | Filing History |
| 2025-05-15 4:29 pm Sale | 2025-03-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | BIOTECHNOLOGY VALUE FUND L P | 4,632,749 9.990% | -201,548 (-4.17%) | Filing History |
| 2025-05-15 4:27 pm Sale | 2025-03-31 | 13G | ELEVATION ONCOLOGY INC ELEV | BIOTECHNOLOGY VALUE FUND L P | 4,440,000 7.000% | -1,790,845 (-28.74%) | Filing History |
| 2025-05-15 4:25 pm Purchase | 2025-03-31 | 13G | CIDARA THERAPEUTICS INC NE CDTX | BIOTECHNOLOGY VALUE FUND L P | 1,252,441 9.990% | 158,942 (+14.54%) | Filing History |
| 2025-05-09 5:50 pm Unchanged | 2025-05-07 | 13D | INVENTIVA SA ADR IVA | BIOTECHNOLOGY VALUE FUND L P | 8,545,499 6.100% | 0 (Unchanged) | Filing History |